RNA Advisors
  • Home
  • Who We Serve
  • What We Do
    • Commercial Operations
    • Strategic Advisory
    • Transactional Support
    • Valuation Advisory
  • Industries
  • About Us
    • Our Team
    • Careers
  • Insights
  • Contact
Select Page
Client Succes: Derivatives Valuation for pre-IPO Biotechnology Company

Client Succes: Derivatives Valuation for pre-IPO Biotechnology Company

by RNA | Oct 20, 2016 | Client Success, Valuation Advisory

THE PROBLEM: A development stage biotechnology company (considering an IPO in the near future) entered into a series of financings which required the valuation of components of the financings deemed to be a derivative for financial reporting purposes. THE SOLUTION:...

Read More

Categories

  • Client Success
  • RNA Team News
  • Strategic Advisory
  • Valuation Advisory

Recent Post

  • Scott Winder
    Scott Winder joins RNA to expand its Life Science Tax and Financial Reporting Valuation Group
  • Fairness Opinions: Why Expertise Matters Now More Than Ever
  • Transaction support
    Client Success: Transaction Support to Assess Value from Different Perspectives
  • Home
  • Who We Serve
  • What We Do
  • Industries
  • About Us
  • Insights
  • Contact

Contact

200 S. Virginia St, 8th Floor
Reno, NV 89501
Phone: 833-421-1159
Email: info@rnaadvisors.com

Follow

  • Follow
© 2023 RNA Advisors, LLC. All rights reserved.